- Interesting Late Stage Viral Vaccine CandidatesPosted 9 days ago
- From Product Candidate to Product: The Road to Commercialization in Regenerative MedicinePosted 31 days ago
- Part III – Fifteen Cell Therapies/Stem Cell Therapies in Phase III Clinical TrialsPosted 38 days ago
- Part II – Fifteen Cell Therapies/Stem Cell Therapies in Phase III Clinical TrialsPosted 45 days ago
- Fifteen Cell and Stem Cell Therapies in Phase III Clinical Trials – Part IPosted 51 days ago
- Biologics Have a Robust Pipeline According to Latest PhRMA ReportPosted 58 days ago
- Biologics Take Top Spots in Best Selling Drugs of 2012Posted 65 days ago
- Best Practices in Cell Therapy ManufacturingPosted 101 days ago
- Can Stable Expression Levels be Achieved in a Transient Expression System – Expi293Posted 114 days ago
- Identifying Options for Stem Cell Based Therapy Scale-upPosted 132 days ago
-
Innovators who Paved the Way for Modern Vaccines
Maurice Hilleman – Measles, Mumps, Rubella I read a great article the other day that I...
-
Interesting Late Stage Viral Vaccine Candidates
In March, the Pharmaceutical Research and Manufacturers of America released a new report “Medicines in Development...
-
Interesting Products Featured at Interphex 2013
Sadly, I did not get to attend Interphex 2013 this year, but I did hear about...
Latest News
-
The Dish’s Weekly News Wrap Up – May 17, 2013
This week’s headlines include, human stem cells created by cloning, cancer drug news, Cambridge hot area for iPS patents, US invokes Emergency Act on H7N9, crowdfunding in biotech, and...
- May 17, 2013
- 0
-
Innovators who Paved the Way for Modern Vaccines
Maurice Hilleman – Measles, Mumps, Rubella I read a great article the other day that I felt needed to be shared. The article is about the incredible work of...
- May 16, 2013
- 0
-
Introducing a New Feature – Ask the Expert
Ask the Expert is an exciting new feature starting today on the Cell Culture Dish where both industry and academic experts answer your questions. A range of topics will...
- May 13, 2013
- 0
-
The Dish’s Weekly News Wrap Up – May 10, 2013
This week’s headlines include, promise of faster drug approvals, bone derived from skin cells, potential biosimilar market growth, Takeda buys Inviragen, some big biotechs are accelerating their R&D spending,...
- May 10, 2013
- 0
-
Interesting Late Stage Viral Vaccine Candidates
In March, the Pharmaceutical Research and Manufacturers of America released a new report “Medicines in Development – Biologics, 2013 Report.” The report lists 907 biologics currently in development by...
- May 9, 2013
- 0
Categories
-
The Dish’s Weekly News Wrap Up – May 17, 2013
This week’s headlines include, human stem cells created by...
- May 17, 2013
- 0
-
Innovators who Paved the Way for Modern Vaccines
Maurice Hilleman – Measles, Mumps, Rubella I read a...
- May 16, 2013
- 0
-
Introducing a New Feature – Ask the Expert
Ask the Expert is an exciting new feature starting...
- May 13, 2013
- 0
-
New Strategies Key to the Clinical Manufacturing of Stem Cells for Therapeutic Use
In May, Osiris’, Prochymal, made history by becoming the...
- June 28, 2012
- 13
-
New Vaccines – Coming Soon to a Doctor’s Office Near You…
There have been some very positive vaccine stories in...
- July 24, 2012
- 12
-
How Stem Cells Can Play a Major Role in Developing New Therapeutics
Stem cells can create systems to mimic healthy cells...
- October 30, 2012
- 10
Recent Video Picks
-
InnovaCoat – A Revolution in Nano-Gold Conjugation
Uploaded on Oct 16, 2012 The InnovaCoat® GOLD conjugation...
- March 4, 2013
- 0
-
3D Cell Culture from N3DBIO
Uploaded on Oct 9, 2012 The Bio-Assembler™ system cultures...
- March 4, 2013
- 0
Recent Posters & Presentations
-
Novel ECM Mimetic Surfaces for Cell Expansion and Differentiation
Corning Life Sciences ASCB December 17, 2012 Marshall Kosovsky,...
- December 17, 2012
- 0
-
Enhanced Growth and Productivity of CHO through rHSA Media Supplementation
Christopher Shen, Kirilynn Svay, Delyan Rusev, Jeffrey Rosenbloom, Dennis...
- May 23, 2012
- 0
-
Biopharma Production
-
Discovery/Development
-
Regulatory & Business
-
Cell Lines
-
Stem Cells
- Part III – Fifteen Cell Therapies/Stem Cell Therapies in Phase III Clinical Trials
- Part II – Fifteen Cell Therapies/Stem Cell Therapies in Phase III Clinical Trials
- Fifteen Cell and Stem Cell Therapies in Phase III Clinical Trials – Part I
- The Value of Cord Blood Stem Cells in Healthcare and Research
-
Vaccine Production
Sponsors and Partners












